Abstract: Disclosed herein are system, method, and computer program product embodiments for optimizing the determination of a phenotypic impact of a molecular variant identified in molecular tests, samples, or reports of subjects by way of regularly incorporating, updating, monitoring, validating, selecting, and auditing the best-performing evidence models for the interpretation of molecular variants across a plurality of evidence classes.
Type:
Application
Filed:
October 17, 2018
Publication date:
June 20, 2019
Applicant:
Jungla Inc.
Inventors:
Alexandre COLAVIN, Carlos L. ARAYA, Jason A. REUTER